Investigating the Association of Vitamin D with Blood Pressure and the Renin-angiotensin-aldosterone System in Hypertensive Subjects: a Cross-sectional Prospective Study

Overview

Journal J Hum Hypertens

Specialty Cardiology & Vascular Diseases

Date 2017 Dec 20

PMID 29255218

Citations 6

Authors

Antoine Cremer

Chloe Tambosco

Jean-Benoit Corcuff

Romain Boulestreau

Prune Gaillard

Marion Laine

Georgios Papaioannou

Philippe Gosse

Affiliations

Soon will be listed here.

Abstract

The hypothesis that vitamin D (25(OH)D) insufficiency plays a role in occurring of various disease has led to a rise in requests of dosages and to an increase of health-care costs. 25(OH)D insufficiency is associated with increased risk of cardiovascular disease and hypertension in many studies. Animal studies demonstrated that 25(OH)D insufficiency activates renin angiotensin system but corresponding humans data are limited. The aim of the study was to document relationship between 25(OH)D, blood pressure, and renin angiotensin system in hypertensive subjects. In all, 248 hypertensive individuals, 46.8 years (±14), were hospitalized for an etiological assessment of hypertension in this cross-sectional study over two calendar years. 25(OH)D, plasma renin activity, and aldosterone were determined in stringent conditions and blood pressure was measure. Statistical analyses were carried out to analyze the association between 25(OH)D, blood pressure, and renin angiotensin system using linear and logistic regressions with adjustments on relevant variables. In all, 80% of the studied population had a 25(OH)D insufficiency. There were no significant association between 25(OH)D and levels of systolic or diastolic blood pressure, plasma renin activity, and aldosterone whatever the statiscal method used after adjustment. 25(OH)D is not associated with blood pressure and renin angiontensin component in hypertensive subjects. These results corroborate the interventional studies which are for a large majority negatives. A new definition of the 25(OH)D insufficiency in general population is necessary.

Citing Articles

High dose cholecalciferol supplementation causing morning blood pressure reduction in patients with type 1 diabetes mellitus and cardiovascular autonomic neuropathy.

Felicio J, Moraes L, Lemos G, Souza I, Vieira G, Silva L Sci Rep. 2024; 14(1):6374.

PMID: 38493259 PMC: 10944468. DOI: 10.1038/s41598-024-56934-1.

Hypertension: Constraining the Expression of ACE-II by Adopting Optimal Macronutrients Diet Predicted via Support Vector Machine.

Khan M, Kalyan G, Chakrabarty S, Mursaleen M Nutrients. 2022; 14(14).

PMID: 35889751 PMC: 9318145. DOI: 10.3390/nu14142794.

The Functional Medicine Approach to COVID-19: Virus-Specific Nutraceutical and Botanical Agents.

Evans J, Luby R, Lukaczer D, Rountree R, Stone P, Guilliams T Integr Med (Encinitas). 2020; 19(Suppl 1):34-42.

PMID: 33041706 PMC: 7482149.

Association of vitamin D status with coronary artery disease in postmenopausal women.

Xu R, Li Y, Ma L, Yang H Medicine (Baltimore). 2020; 99(11):e19544.

PMID: 32176108 PMC: 7440073. DOI: 10.1097/MD.0000000000019544.

Effects of Vitamin D Supplementation on Renin and Aldosterone Concentrations in Patients with Advanced Heart Failure: The EVITA Trial.

Zittermann A, Ernst J, Prokop S, Fuchs U, Dreier J, Kuhn J Int J Endocrinol. 2018; 2018:5015417.

PMID: 30057603 PMC: 6051119. DOI: 10.1155/2018/5015417.

References

Arora P, Song Y, Dusek J, Plotnikoff G, Sabatine M, Cheng S . Vitamin D therapy in individuals with prehypertension or hypertension: the DAYLIGHT trial. Circulation. 2014; 131(3):254-62. DOI: 10.1161/CIRCULATIONAHA.114.011732. View

Scragg R, Glover M . Parental and adolescent smoking: does the association vary with gender and ethnicity?. N Z Med J. 2007; 120(1267):U2862. View

Margolis K, Martin L, Ray R, Kerby T, Allison M, Curb J . A prospective study of serum 25-hydroxyvitamin D levels, blood pressure, and incident hypertension in postmenopausal women. Am J Epidemiol. 2011; 175(1):22-32. PMC: 3291161. DOI: 10.1093/aje/kwr274. View

Kunutsor S, Apekey T, Steur M . Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants. Eur J Epidemiol. 2013; 28(3):205-21. DOI: 10.1007/s10654-013-9790-2. View

Ginde A, Liu M, Camargo Jr C . Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med. 2009; 169(6):626-32. PMC: 3447083. DOI: 10.1001/archinternmed.2008.604. View

Brossaud J, Corcuff J . Pre-analytical and analytical considerations for the determination of plasma renin activity. Clin Chim Acta. 2009; 410(1-2):90-2. DOI: 10.1016/j.cca.2009.09.018. View

Holick M, Siris E, Binkley N, Beard M, Khan A, Katzer J . Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab. 2005; 90(6):3215-24. DOI: 10.1210/jc.2004-2364. View

Rosecrans R, Dohnal J . Seasonal vitamin D changes and the impact on health risk assessment. Clin Biochem. 2014; 47(7-8):670-2. DOI: 10.1016/j.clinbiochem.2014.02.004. View

Witham M, Ireland S, Houston J, Gandy S, Waugh S, MacDonald T . Vitamin D therapy to reduce blood pressure and left ventricular hypertrophy in resistant hypertension: randomized, controlled trial. Hypertension. 2014; 63(4):706-12. DOI: 10.1161/HYPERTENSIONAHA.113.02177. View

10.

Grubler M, Gaksch M, Kienreich K, Verheyen N, Schmid J, O Hartaigh B . Effects of Vitamin D Supplementation on Plasma Aldosterone and Renin-A Randomized Placebo-Controlled Trial. J Clin Hypertens (Greenwich). 2016; 18(7):608-13. PMC: 8032175. DOI: 10.1111/jch.12825. View

11.

Lind L, Wide L, Sorensen O, Ljunghall S . An association between mineral metabolism and the renin-aldosterone system in human hypertension. J Hum Hypertens. 1989; 3(2):137-40. View

12.

Chen T, Chimeh F, Lu Z, Mathieu J, Person K, Zhang A . Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Biochem Biophys. 2007; 460(2):213-7. PMC: 2698590. DOI: 10.1016/j.abb.2006.12.017. View

13.

Li Y, Kong J, Wei M, Chen Z, Liu S, Cao L . 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002; 110(2):229-38. PMC: 151055. DOI: 10.1172/JCI15219. View

14.

Witham M, Price R, Struthers A, Donnan P, Messow C, Ford I . Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial. JAMA Intern Med. 2013; 173(18):1672-9. DOI: 10.1001/jamainternmed.2013.9043. View

15.

Snijder M, Lips P, Seidell J, Visser M, Deeg D, Dekker J . Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J Intern Med. 2007; 261(6):558-65. DOI: 10.1111/j.1365-2796.2007.01778.x. View

16.

Clemens T, Adams J, Henderson S, Holick M . Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet. 1982; 1(8263):74-6. DOI: 10.1016/s0140-6736(82)90214-8. View

17.

Mitchell D, Henao M, Finkelstein J, Burnett-Bowie S . Prevalence and predictors of vitamin D deficiency in healthy adults. Endocr Pract. 2012; 18(6):914-23. PMC: 3755751. DOI: 10.4158/EP12072.OR. View

18.

Lagunova Z, Porojnicu A, Lindberg F, Hexeberg S, Moan J . The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res. 2009; 29(9):3713-20. View

19.

Forman J, Williams J, Fisher N . Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension. 2010; 55(5):1283-8. PMC: 3023301. DOI: 10.1161/HYPERTENSIONAHA.109.148619. View

20.

Pilz S, Gaksch M, Kienreich K, Grubler M, Verheyen N, Fahrleitner-Pammer A . Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial. Hypertension. 2015; 65(6):1195-201. DOI: 10.1161/HYPERTENSIONAHA.115.05319. View